Results 161 to 170 of about 1,306,169 (311)

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

RNA delivery with a human virus-like particle [PDF]

Nature Biotechnology, 2021
Anna Gutkin, Daniel Rosenblum, Dan Peer
openaire   +2 more sources

Reconceptualising ‘agency in mobility’: Agency for becoming and other forms of agency in study abroad

British Educational Research Journal, EarlyView.
Abstract Study‐abroad programs are increasingly adopted and supported by institutions and governments as a strategic tool for deepening internationalisation and public diplomacy through people‐to‐people, institution‐to‐institution and country‐to‐country connections.
Ly Thi Tran, Thinh Huynh
wiley   +1 more source

Pitfalls of the New Age: Nature and Motherhood in Humanizing Delivery and Birth in Brazil

Revista Estudos Feministas, 2002
This essay attempts at a brief chracterization of the “Movimento pela Humanização do Parto e do Nascimento” (Movement for the Humanization of Delivery and Birth) in Brazil.
Carmen Susana Tornquist
doaj  

Growing an Inclusive Ecological Professional Society for a Diverse Environmental Workforce: Wisdom Gained to Navigate Current and Future DEIJ Challenges

The Bulletin of the Ecological Society of America, EarlyView.
Abstract The Ecological Society of America (ESA) is a global leader in shaping the science, teaching, and culture of ecology. Since the 1980s, ESA has undergone transformational changes in its structure, governance, and how it prioritizes diversity, equity, inclusion, and justice (DEIJ) endeavors in all its functions.
Carmen R. Cid, Karen M. Bailey, Gillian Bowser, Maria C. Cerón‐Castilla, Wilnelia Recart González, Danielle Ignace, Leanne M. Jablonski, Gaurav Kandlikar, Kenneth M. Klemow, Matthew A. McCary, George A. Middendorf, Robert Newman, Luanna B. Prevost, Bruno Soares   +13 more
wiley   +1 more source

Nonhuman Mobilities and Multispecies Border Regimes in (Post‐)Colonial Southern Africa**

Berichte zur Wissenschaftsgeschichte, EarlyView.
This article explores how borders in Southern Africa—such as Namibia's internal veterinary and settler border (Red Line) and national borders between Namibia, South Africa, and Botswana—functioned not only as territorial dividers but as tools to shape colonial and postcolonial multispecies hierarchies. These borders regulated human and animal movement,
Luregn Lenggenhager
wiley   +1 more source

Cell and Gene Therapies Manufacturing Challenges and Integrated Good Manufacturing Practices Solutions: A Lifecycle Perspective

Biotechnology and Bioengineering, EarlyView.
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga, Udisha Singh, Sachin Dattram Pawar   +2 more
wiley   +1 more source

Carrier‐free self‐assembled nanomedicine for combination‐therapy of acute myeloid leukemia

BMEMat, EarlyView.
CPDS combines drugs with three different mechanisms of action to achieve a multi‐mechanism combination therapy for AML by directly killing tumor cells and activating anti‐tumor immunity. Abstract As the main acute myeloid leukemia (AML) clinical treatment, the chemotherapy alone cannot meet the clinical therapeutic needs due to the high heterogeneity ...
Meihong Chai, Rui Zhang, Haiyin Yang, Jiyue Xing, Tianyuan Hu, Mengxi Zhu, Rui Li, Xiaoli Chen, Beibei Zhao, Yang Lan, Stefan Barth, Yuanyu Huang, Li Zhang, Mengjie Zhang, Huining He   +14 more
wiley   +1 more source

Tackling cancer stemness with nanotechnology in the era of precision medicine

BMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo, Shun Yao, Lihui Meng, Chunyuan Chen, Yuechu Lucinda Lu, Rong Lu, Kashif Rafiq Zahid, Umar Raza, Qingzhi Wu, Wenli Chen   +9 more
wiley   +1 more source